Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters (original) (raw)
Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
Catherine O'Connor
PLoS ONE, 2012
View PDFchevron_right
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK
Dimitrios Paraskevis
Journal of the International AIDS Society
View PDFchevron_right
Efficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia
Bui Huy
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
View PDFchevron_right
Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort
Enric Pedrol
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
Determinants of Highly Active Antiretroviral Therapy Duration in HIV-1-Infected Children and Adolescents in Madrid, Spain, from 1996 to 2012
Verónica Briz
PLoS ONE, 2014
View PDFchevron_right
HIV management in practice
Theresa Rossouw
Continuing Medical Education, 2011
View PDFchevron_right
Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
Ruben Lopez
PLoS Medicine, 2012
View PDFchevron_right
Short-Course Antiretroviral Therapy in Primary HIV Infection
Mauro Schechter
New England Journal of Medicine, 2013
View PDFchevron_right
Treatment of AIDS and HIV- Related Conditions: 2000
Betty Dong
Journal of the American Board of Family Medicine, 2000
View PDFchevron_right
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Victor Mudhune
The Journal of Infectious Diseases, 2013
View PDFchevron_right
Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy
Seema Patrikar
Medical journal, Armed Forces India, 2017
View PDFchevron_right
Antiretroviral Therapy in HIV Infection
Bruce j. Brew
Archives of Neurology, 2004
View PDFchevron_right
Evaluation of Virologic Monitoring Frequencies on Responses to Antiretroviral Therapy in HIV-1 Infected Patients
Mokgadi Matlakala
SSRN Electronic Journal, 2018
View PDFchevron_right
Treatment of AIDS and HIV-Related Conditions-1999
Betty Dong
Journal of the American Board of Family Medicine, 1999
View PDFchevron_right
The Health of People Living With HIV
Daliah Heller
Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2002
View PDFchevron_right
Effect of Improved access to Antiretroviral Therapy
Julius C Mwita
2013
View PDFchevron_right
The Womenʼs Interagency HIV Study
Henry Sacks
Epidemiology, 1998
View PDFchevron_right
Changes in cardiovascular risk and clinical outcomes in a HIV/AIDS cohort study over a 1-year period at a specialized clinic in Mexico
Miguel A Sánchez-Alemán
Therapeutics and Clinical Risk Management, 2018
View PDFchevron_right
Evaluation of Adherence to Antiretroviral Therapy in Italian HIV Patients
Luca Lazzarini
AIDS Patient Care and STDs, 2003
View PDFchevron_right
Treatment outcomes after 7 years of public-sector HIV treatment
Ian Sanne
AIDS, 2012
View PDFchevron_right
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe
Ricardo Camacho
Journal of Infectious Diseases, 2013
View PDFchevron_right